Merrimack Pharma (MACK) Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend May 30, 2019 04:34PM
Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend May 30, 2019 04:05PM
Merrimack Reports First Quarter 2019 Financial Results May 10, 2019 07:30AM
Pre-Open Stock Movers 04/05: (BOOT) (TGI) (RIOT) Higher; (SYRS) (AQB) (DLTH) Lower (more...) Apr 5, 2019 09:31AM
After-Hours Movers 04/04: (BOOT) (TGI) (FC) Higher; (AQB) (DLTH) (SRYS) (more...) Apr 4, 2019 05:23PM


Apr 4, 2019 04:16PM Merrimack Pharma (MACK) Says it's Discontinuing Development of MM-310
Apr 4, 2019 04:15PM Merrimack Discontinues Development of MM-310
Nov 7, 2018 06:51AM Merrimack Pharma (MACK) Misses Q3 EPS by 65c, Initiate Corporate Restructuring
Nov 7, 2018 06:45AM Merrimack Reports Third Quarter 2018 Financial Results and Provides Strategic Update Following Portfolio Review
Mar 1, 2017 07:00AM Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results
Jan 8, 2017 09:45PM France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 billion deal
Nov 9, 2016 04:02PM Merrimack Reports Third Quarter 2016 Financial Results
Oct 3, 2016 09:20AM Pre-Open Stock Movers 10/03: (VHC) (FVE) (CAB) Higher; (MACK) (TASR) (HRTX) Lower (more...)
Oct 3, 2016 07:16AM Merrimack Pharma (MACK) to Undertake Major Corporate Restructuring; Will Cut Workforce by ~22%
Oct 3, 2016 07:15AM Merrimack Announces Major Corporate Restructuring